• 07/10/2021

    The first patients in Kyrgyzstan to receive innovative drug regimen BPaL

    KNCV Tuberculosis Foundation Kyrgyzstan (KNCV-KG), is partnering with the National Center of Phthisiology to implement the innovative short duration all-oral…

    Lees meer
  • Global Fund Results Report

    21/09/2021

    Global Fund Results Report ‘heartbreaking’ says KNCV executive director Mustapha Gidado

    The COVID-19 pandemic had a devastating impact on the fight against HIV, TB and malaria in 2020, according to a…

    Lees meer

  • 14/09/2021

    Save the date: Optimized models of care for TB prevention among migrants

    Please save the date on Tuesday the 7th of December, on which we would like to welcome you to a symposium…

    Lees meer

  • 13/09/2021

    The People-Centred Framework for TB Programming – Webinar showcasing

    On Thursday 2nd September 2021, KNCV hosted a webinar to officially launch and showcase the new…

    Lees meer

  • 07/09/2021

    Devex interview about digital adherence technologies: “We hope that our research will contribute to the WHO policy”

    Over the years, digital technologies have been introduced to improve patients’ adherence to tuberculosis (TB) treatment, but with little research…

    Lees meer

  • 02/09/2021

    Kick off collaboration Obafemi Awolowo University Teaching Hospital and KNCV Tuberculosis Foundation

    We are happy to announce the collaboration between the Obafemi Awolowo University Teaching Hospital (OAUTH) and KNCV Tuberculosis…

    Lees meer

  • 25/08/2021

    Webinar: People-Centred Framework Knowledge Hub

    On September 2, at 2 pm CEST a webinar is held to showcase the People-Centred Framework (PCF) Knowledge Hub. The…

    Lees meer

  • 20/08/2021

    New partnership between GC Labs and KNCV Tuberculosis Foundation to strengthen tuberculosis treatment safety monitoring

    GC Labs and KNCV Tuberculosis Foundation (KNCV) will present their newly formed alliance during an…

    Lees meer

  • 10/08/2021

    Publication: SOS stool method can be rolled out to Xpert sites, for a child-friendlier tuberculosis diagnosis closer to point of care

    This study, conducted by KNCV Tuberculosis Foundation, shows that a simple stool processing method can detect Mycobacterium tuberculosis and resistance…

    Lees meer

  • 04/08/2021

    Research begins into new digital tools to support patients and healthcare workers through tuberculosis treatment

    A large global study which aims to determine if digital adherence technologies can provide more patient-friendly approaches to improve tuberculosis…

    Lees meer

  • 19/07/2021

    Publication: Results of the acceptability & feasibility study of the BPaL regimen

    A study, conducted by KNCV Tuberculosis Foundation and TB Alliance, shows that the adoption of BPal…

    Lees meer

  • 15/07/2021

    New Trial Results Show Effectiveness of BPaL Regimen for Highly Drug-Resistant TB Can Be Maintained with Reduced Dosing of Linezolid

    TB Alliance’s ZeNix trial in South Africa and Eastern Europe sought to optimize the 6-month treatment regimen with reduced exposure…

    Lees meer

  • 15/07/2021

    Launch of UNITE4TB partnership marks a new era in Tuberculosis treatment development

    15 July 2021, The Hague. To advance anti-tuberculosis (TB) science and enable the progression of new, safe, and affordable treatment solutions…

    Lees meer

  • 18/06/2021

    Welcome Dr. Harsh Vardhan, India’s Minister of Health, as new Chair of Stop TB Partnership

    KNCV Tuberculosis Foundation welcomes His Excellency Dr. Harsh Vardhan as the new chair of the Stop TB Partnership Board. We are confident that…

    Lees meer

  • 21/05/2021

    Appointments Board of Trustees

    May 11, 2021 the KNCV Members Association appointed Tjipke Bergsma and René Stumpel to the Board of Trustees and re-appointed…

    Lees meer
Bezoek Nederlandse website

KNCV has been fighting TB since its establishment in 1903. Over the past 117 years, the organization has acquired indispensable knowledge and experience in the field of effective TB control, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework
Our patroness
Partner with us

Cambodia
Eswatini
Ethiopia
Ghana
Indonesia
Kazachstan
Kenya
Kyrgyzstan
Malawi
Namibia
Nigeria
Rwanda
South Africa
Tajikistan
Tanzania
Ukraine
Vietnam
Zambia

Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.

Patient stories

The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi

KNCV’s Technical Assistance Strategy

New drugs & treatment regimens
Digital health solutions
Diagnosis & treatment of LTBI
TB Stigma reduction
Epidemiological measurement methodologies
New diagnostics and lab network design
People-Centred Framework for National Strategic Planning and HSS
Blended learning platform & methodologies

ASCENT
ASTTIE
Development of a comprehensive Digital Training Package
E-detect
GeneXpert MTB/RIF Test
IMPAACT4TB
PAVIA
People-Centered Framework for TB Programming
PODTEC
TB Alliance BPAL Project
The Global Fund to Fight AIDS, Tuberculosis and Malaria
TREATS

Our success stories

Challenge TB
Improved TB/HIV Prevention & Care – Building Models for the Future Project
TB REACH Ethiopia
TB REACH Nigeria
TB REACH Philippines
TB REACH Tanzania

KNCV Webinar: Impact of COVID-19: Hear the perspective of TB/MDR-TB patients and front line health care workers
KNCV Webinar: Contact Investigation for COVID-19: Lessons from TB Control Programs
KNCV Webinar ‘Infection prevention and control for COVID-19

Annual Report 2020
KNCV 2-pager ASCENT
KNCV 2-pager Childhood TB
KNCV 2-pager Digital Health
KNCV 2-pager General
KNCV 2pager Right Diagnosis, Right Treatment
KNCV 2-pager TB Photovoices
KNCV 2-pager TB Stigma

Address

KNCV Tuberculosefonds
Maanweg 174
2516 AB Den Haag
+31 70 416 7222

OPEN IN GOOGLE MAPS

Postal address

Postbus 146
2501 CC Den Haag

More information

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.